SCHEMBL19902734

SCHEMBL19902734

CCc1ncccc1C(=N)Nc1ccc(C)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
NPC1 O15118 9/20 0.46
RAB9A P51151 8/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
SMN1; SMN2 Q16637 5/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
KDR P35968 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 4/20 0.42
AHR P35869 1/20 0.42
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19902802 0.89 KDM4E (0.47) KDM4ENPC1RAB9ACASP3SENP8
SCHEMBL19902738 0.85 RAB9A (0.46) KDM4ENPC1RAB9ASMN1; SMN2CYP1A2
SCHEMBL19902747 0.84 ATM (0.46) KDM4ESMN1; SMN2CYP1A2CYP2C9CYP2C19
SCHEMBL17064036 0.80 P2RX7 (0.38) KDM4ENPC1L3MBTL1MAPTALDH1A1
SCHEMBL1460028 0.77 P2RX7 (0.46) KDM4ENPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL19902741 0.77 KDM4E (0.52) KDM4ENPC1RAB9ACASP3SENP8
SCHEMBL11452798 0.76 NPC1 (0.48) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL19902793 0.73 ALDH1A1 (0.38) KDM4ESMN1; SMN2L3MBTL1CYP2C9NPSR1
SCHEMBL5056591 0.73 ALDH1A1 (0.41) KDM4ENPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL19902767 0.71 RAB9A (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3033337-B1 SUBSTITUTED IMIDAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS JANSSEN PHARMACEUTICA NV (BE) 2018-02-28 EP disclosed